novo nordisk glp-1 patent litigation Looming drug expirations draw generics firms Novo's GLP-1 Patent Suit Against
Description
In clinical trials, neither weight gain nor weight loss was consistently reported as a side effect
HenneyAERileyDRHydesTJAnsonMIbarburuGHFrostFet al
January 26, 2025
GLP-1 medications mimic a natural hormone that slows stomach emptying and reduces appetite
, Gutniak, M
